Survival of Post-Transplant Lymphoproliferative Disorder after Kidney Transplantation in Patients under Rapamycin Treatment

Background: One of the important causes of mortality and morbidity in kidney transplanted patients is Post Transplant Lymphoproliferative Disease (PTLD), which is due to immunosuppression therapy and viral activity. It seems that Rapamycin, with dual antineoplastic and immunosuppressive effects, may...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashrafi, Farzaneh, Shahidi, Shahrzad, Mehrzad, Valiollah, Mortazavi, Mojgan, Hosseini, Sayyideh Forough
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888361/
https://www.ncbi.nlm.nih.gov/pubmed/35291663
http://dx.doi.org/10.18502/ijhoscr.v15i4.7479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888361/
https://www.ncbi.nlm.nih.gov/pubmed/35291663
http://dx.doi.org/10.18502/ijhoscr.v15i4.7479

Ejemplares similares